Valuation: LifeMD, Inc.

Market Cap 83.87M 75.21M 69.32M 62.95M 119M 7.86B 122M 830M 331M 4.21B 315M 308M 13.32B P/E 2026 *
-3.36x
P/E 2027 * -19x
Enterprise Value 83.87M 75.21M 69.32M 62.95M 119M 7.86B 122M 830M 331M 4.21B 315M 308M 13.32B EV / Sales 2026 *
0.4x
EV / Sales 2027 * 0.34x
Free-Float
84.02%
Yield 2026 *
-
Yield 2027 * -
1 day-16.95%
1 week-20.18%
Current month-24.02%
1 month-33.84%
3 months-51.93%
6 months-63.60%
Current year-48.97%
1 week 1.7
Extreme 1.695
2.49
1 month 1.7
Extreme 1.695
2.65
Current year 1.7
Extreme 1.695
5.38
1 year 1.7
Extreme 1.695
5.38
3 years 1.7
Extreme 1.695
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 43 -
Director of Finance/CFO 58 15/03/2026
Chief Tech/Sci/R&D Officer - 31/05/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 03/09/2014
Chairman 43 10/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
11/08/26 Free

Director

35,000 0.0724%
11/08/26 Free

Director

35,000 0.0724%
11/08/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
-16.95%-20.18%-66.08%-74.71% 83.87M
-0.48%+2.84%+24.61%+60.16% 266B
+0.42%+2.61%+11.81%+19.85% 166B
-2.28%+2.11%-21.90%+62.18% 156B
+1.54%+2.76%-55.70%-13.30% 64.79B
-0.67%+9.27%+23.70%+61.98% 59.81B
+0.71%-0.95%-0.97%-9.81% 53.3B
-1.27%+1.38%+21.54%+63.99% 50.15B
-0.28%+0.77%+3.31%+85.09% 49.47B
-0.25%+3.40%+26.28%+85.81% 46.72B
Average -1.96%+0.75%-3.34%+34.12% 91B
Weighted average by Cap. -0.45%+3.00%+5.83%+46.85%

Financials

2026 *2027 *
Net sales 208M 186M 172M 156M 295M 19.46B 303M 2.05B 818M 10.43B 779M 763M 32.96B 245M 220M 203M 184M 348M 22.98B 358M 2.43B 966M 12.31B 920M 900M 38.92B
Net income -24.81M -22.25M -20.5M -18.62M -35.24M -2.33B -36.22M -245M -97.8M -1.25B -93.09M -91.12M -3.94B -4.54M -4.08M -3.76M -3.41M -6.46M -426M -6.64M -44.97M -17.92M -228M -17.06M -16.69M -722M
Net Debt - -
Projected Income Statement - Annual - LifeMD, Inc.
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
10/11/26 US$1.740 -16.95% 2,296,531
09/11/26 US$2.095 -11.60% 2,199,430
06/11/26 US$2.370 +3.49% 920,650
05/11/26 US$2.290 -6.53% 597,206
04/11/26 US$2.450 +12.39% 712,258
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - LifeMD, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.740USD
Average target price
8.125USD
Spread / Average Target
+366.95%
  1. Stock Market
  2. Stocks
  3. LFMD Stock